News & Events
Vensica Medical Advances Needle-Free Bladder Therapy to Phase 2
Vensica received FDA IND clearance to initiate Phase 2 study of ViXe, its needle-free Xeomin® delivery system for overactive bladder.
EcoPhage Submits EcoStraw® to EPA
Submission expands sustainable solutions for U.S. strawberry growers
Celleste Bio™ Unveils World’s First Milk Chocolate Bars Made with Cell Cultured Cocoa Butter
Milestone solidifies Celleste's capabilities to create scalable, commercial supply of real cocoa butter
Seger Surgical Solutions Achieves Milestone with Successful Human Trials of Laparoscopic Bowel Closure Device
Three Successful First-in-Human Cases Completed in El Salvador
IBI Ag Announces Successful Development of AI-Driven De Novo Protein Design Platform for Bioinsecticides
POC included in vivo insect validation of de novo designed proteins
Arcuro Medical Significantly Expands SuperBall® Market Opportunity with New Rotator Cuff Repair System; Launches Newly-Enhanced Meniscus Repair System
New indications and enhancements target a potential $1.1 billion addressable market by 2028
Phytolon Achieves Major FDA Regulatory Milestone Paving the Way for Commercialization
The FDA approval paves the way for U.S. commercialization and uses across a wide range of food categories
IBI Ag Completes $10 Million Series A Round Led by Corteva
This is the second and final tranche of IBI Ag’s Series A Round for its novel bioinsecticide platform
Celleste Bio™ Announces Major Milestone for Cocoa Industry: Production of First Chocolate Grade Cocoa Butter Using Cell Cultured Technology